论文部分内容阅读
为了降低重症病毒性肝炎的病死率,上海第二医科大学附属瑞金医院(任组长单位)、天津市传染病医院、中国医科大学和重庆医科大学四个单位协作,于1983年开始了关于重症肝炎的治疗与机理研究。二年多来,该协作组共治疗了重症肝炎121例,其中急重肝10例、亚急重肝111例(慢性重症肝炎暂未作研究对象)。所有病例均有病理学依据(肝活检病理标本),且绝大多数病理标本经卫生部肝炎专题委员会病理组共同读片认可。所有病例均作了病原学检测。对上述病人从6个方面进行了治疗。 1. 抗病毒疗法部分病例应用了大剂量人白细胞干扰素(早期病例因当时无药
In order to reduce the mortality of severe viral hepatitis, Shanghai Second Medical University Affiliated Ruijin Hospital (unit leader), Tianjin Infectious Diseases Hospital, China Medical University and Chongqing Medical University, four units in collaboration, in 1983 began on the severity Hepatitis treatment and mechanism research. In the past two years, 121 cases of severe hepatitis were treated in this cooperative group, including 10 cases of acute severe hepatitis and 111 cases of subacute severe hepatitis (chronic severe hepatitis was not yet studied). All cases were pathologically based (liver biopsy specimens), and the vast majority of pathological specimens by the Ministry of Health Committee of Hepatology jointly read the film approved. All cases were etiologically tested. The above patients were treated from 6 aspects. 1. Antiviral therapy in some cases the application of high-dose human leukocyte interferon (early cases because there was no medicine